YouSigma- the web's most extensive resource for information
$6.99 Domain Names at Network Solutions®!
Abbott Laboratories (SWOT Analysis)

Go to Home Page

Tell your friend about this WebSite!

Download PDF Version!

“SWOT is an acronym for the internal Strengths and Weaknesses of a firm and the environmental Opportunities and Threats facing that firm. SWOT analysis is a widely used technique through which managers create a quick overview of a company’s strategic situation. The technique is based on the assumption that an effective strategy derives from a sound “fit” between a firm’s internal resources (strengths and weaknesses) and its external situation (opportunities and threats). A good fit maximizes a firm’s strengths and opportunities and minimizes its weaknesses and threats. Accurately applied, this simple assumption has powerful implications for the design of a successful strategy.”

Abbott Laboratories 

Abbott Laboratories (Abbott) is a global, health care company engaged in the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company has presence in more than 130 countries. The increasing acceptance of Abbott's Humira in the autoimmune disorder market will be the major growth driver of the company's top-line growth out to 2013. However, the introduction of biologic products in the autoimmune market could affect the company's forecast product sales during the period.

Strengths, Weaknesses, Opportunities and Threats (SWOT)

Location of Factor

TYPE OF FACTOR

Favorable

Unfavorable

Internal

Strengths

  • Continued uptake of Humira across autoimmune disorder market
  • Diverse lipid management portfolio
  • Blockbuster HIV franchise

Weaknesses

  • Patent exposure set to weaken prescription pharma portfolio
  • Narrow launch prospects largely restricted to follow-on medications

External

Opportunities

  • Exciting prospect for lucrative vascular intervention segment in Xience V
  • Early stage pipeline programs in oncology, CNS and immunology

Threats

  • FTC investigation into generic defence strategies
  • New biologic launches for autoimmune disorder market
underline
About YouSigma Please Donate Using PayPal, to help us Develop Content
Copyright and Disclaimer
Loading
underline
underline
Try a free sample Destiny Reading! Executive Openings! $80,000 to $500,000+
"Abbott Laboratories (SWOT Analysis)";